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Human and mouse prion proteins share a structural motif 
that regulates resistance to common chronic wasting dis-
ease (CWD) prion strains. Successful transmission of an 
emergent strain of CWD prion, H95+, into mice resulted 
in infection. Thus, emergent CWD prion strains may have 
higher zoonotic potential than common strains.
Chronic wasting disease (CWD) is a contagious prion disease of cervids that is spreading globally. CWD is 
enzootic in multiple cervid species, including deer and elk; 
the major foci of disease are Colorado/Wyoming (USA), 
Wisconsin/Illinois (USA), and Alberta/Saskatchewan (Can-
ada). CWD is also present in captive cervids in South Korea 
and wild reindeer and moose in Norway (https://www.nwhc.
usgs.gov/images/cwd/cwd_map.jpg). CWD results from the 
conformational transformation of the host-encoded cellular 
prion protein (PrPC) into protease-resistant, detergent-insol-
uble, β-sheet rich, amyloidogenic conformers, termed prions 
(PrPCWD). Within their conformation, prion strains encipher 
the information that directs the templated misfolding and ag-
gregation of PrPC molecules into additional prions (1).
Although the sequence homology of PrP among mam-
mals is high, the ability of particular prion strains to cause dis-
ease in different species is determined by the conformational 
compatibility between a given strain and the host PrPC (2). We 
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previously identified 2 strains of CWD prion in white-tailed 
deer (3), Wisc-1 and H95+; these strains exhibit distinct bio-
logical properties in deer and transgenic cervidized mice. To 
ascertain the host range of different strains from cervids, we 
inoculated CWD prions isolated from experimentally infect-
ed deer with different PRNP genotypes (Q95G96 [wild type 
(wt)], S96/wt, H95/wt, and H95/S96) and from elk (CWD2 
strain) into hamsters and mice. All isolates have been success-
fully transmitted into transgenic mice expressing wt cervid 
PrP and contain high titers of CWD prions (3).
Mice inoculated with H95+ CWD prions succumbed to 
clinical disease at 575 ± 47 or 692 ± 9 days, depending on 
the H95+ isolate (Table). Mice inoculated with Wisc-1 or 
elk CWD or uninfected deer homogenates were euthanized 
at day 708 after infection with no signs of prion disease. 
Clinical signs of H95+ CWD in C57Bl/6 mice included 
ataxia, lethargy, tail rigidity, and dermatitis. Protease-re-
sistant PrPCWD was present in all mice infected with H95+ 
prions and was not detected in mice infected with Wisc-1 
or CWD2 (online Technical Appendix, https://wwwnc.cdc.
gov/EID/article/23/9/16-1474-Techapp1.pdf).
In contrast to mice, hamsters succumbed to clinical dis-
ease when inoculated with Wisc-1 CWD prions but were less 
susceptible to H95+ CWD prions (Table). Clinical signs of 
CWD in hamsters began with lethargy and, upon arousal, 
retrocollis; as the disease progressed, lethargy declined with 
increased dystonic movement including ataxia and tremors. 
Hyperesthesia was not observed. Subclinical disease (no 
clinical signs but PrP-res positive by Western blot) was ob-
served in a subset of hamsters (online Technical Appendix).
Successful interspecies prion transmission at the mo-
lecular level depends on the compatibility of the invading 
prion conformers and structural determinants imposed by 
host PrPC. One structural motif is the loop region between 
β sheet 2 and α helix 2 of PRPC at aa 170–174 (online Tech-
nical Appendix). Host species containing PrPC molecules 
with a flexible β2-α2 loop (mice and humans) are hypoth-
esized to be incompatible with prions derived from spe-
cies containing a rigid loop (deer and elk) (4,5). Previous 
attempts to transmit CWD to mice have failed (6,7). Our 
data show that prions from a prototypic rigid-loop species 
(deer) can transmit to a flexible-loop species (mice). The 
transmission is strain dependent. H95+ overrides the con-
formational restriction imposed by the mouse PrP flexible 
loop that Wisc-1 and CWD2 cannot overcome, suggesting 
that the invading prion strain is a dominant contributor to 
the species/transmission barrier. How the N terminal amino 
acid polymorphism (Q95H) affects the conformation of 
PrP, altering the deer-to-mouse transmission barrier, is un-
known. Further structural studies may clarify the effect of 
N terminal residues on β2-α2 loop rigidity.
Transmission of H95+ CWD prions to mice further 
confirms the value of specifying strain when defining 
species barriers. Experimental transmission of CWD pri-
on into macaques and transgenic mice expressing human 
PrP suggests a considerable transmission barrier to CWD 
prions (although squirrel monkeys are susceptible), and 
human prion protein is converted inefficiently in vitro 
(8,9). Successful infection of a flexible-loop species 
(mice) with H95+ CWD raises concerns for the poten-
tial pathogenicity of H95+ prions to other flexible-loop 
species. Transmission studies with Wisc-1 and H95+ in 
transgenic humanized and bovinized mice are ongoing.
The increasing prevalence of CWD indicates selection 
for cervids with resistance alleles, such as S96 and H95. Ge-
netic resistance to a given prion strain selects for the emer-
gence of novel prion strains with altered properties such as 
H95+ and Nor98 (3,10). The iterative transmission of CWD 
prions to cervids with protective alleles of PrPC and the con-
sequent emergence of new CWD prion strains highlights the 
dynamics of the CWD panzootic and the value of character-
izing the host range of emergent CWD prion strains.
 
Table. Results of CWD prion inoculation into rodents* 
Recipient and CWD 
inocula No. 
PrP-res+ 
Incubation period, d Clinical Subclinical 
Mice     
 wt/wt 6 0 0 NA 
 S96/wt 6 0 0 NA 
 H95/wt 7 5 2 669, 671, 706, 706, 706 
 H95/S96 7 7 0 306, 593, 593, 593, 593, 673, 675 
 Elk 4 0 0 NA 
 Control 4 0 0 NA 
Hamsters     
 wt/wt 8 3 5 652, 653, 653 
 S96/wt 8 1 4 634 
 H95/wt 8 1 6 652 
 H95/S96 8 0 1 NA 
 Elk 8 2 2 673, 719 
 Control 8 0 0 NA 
*Mice infected with CWD prions were observed for up to 708 d; hamsters infected with white-tailed deer and elk CWD prions were observed for 659 and 
726 d, respectively. Control mice and hamsters were inoculated with brain homogenates from CWD-negative wt/wt deer. CWD, chronic wasting disease; 
NA, not applicable; PrP-res+, positive for proteinase-K–resistant prion protein; wt, wild type. 
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We report rabies virus transmission among solid organ 
transplantation recipients in Changsha, China, in 2016. 
Two recipients were confirmed to have rabies and died. Our 
findings suggest that more attention should be paid to the 
possibility of rabies virus transmission through organ trans-
plantation for clinical and public health reasons.
In 2016, Zhou et al. reported a case of rabies virus trans-mission in China that was probably a result of organ 
transplantation (1). We report on rabies transmission that 
occurred among solid organ transplant recipients in Chang-
sha, China, during December 2015–January 2016.
In November 2015, the donor, a previously healthy boy, 
showed development of fever, insomnia, and agitation. On 
day 6 of infection, these symptoms progressed, and he was 
sent to a healthcare center. At this time, he experienced wea-
riness, no desire to drink water, poor appetite, and panic. 
One day later, he began vomiting, and was admitted to a 
local hospital (hospital A), where he exhibited anemopho-
bia, convulsions, limb rigidity, and hypersalivation. The 
patient was moved to hospital B (days 7–14) in Changsha. 
At admission, some examination findings indicated a pos-
sibility of viral encephalitis (online Technical Appendix, 
Table 1, https://wwwnc.cdc.gov/EID/article/23/9/16-1704-
Techapp1.pdf). Subhypothermia hibernation therapy and 
assisted ventilation were administered within 72 hours of 
admission, and the patient’s vital signs became stable. On 
day 10, hyponatremia was observed, and on day 11, the pa-
tient again became febrile and tachycardic, with hyperten-
sive abdominal distention and alimentary tract hemorrhage. 
On day 13, viral encephalitis was diagnosed, and rabies was 
suspected. However, rabies virus antibody tests performed 
on serum samples by using ELISA yielded negative results. 
On day 14, the patient was transferred to hospital C, 
where he became comatose and was declared brain dead. 
Permission was granted for organ donation, because no 
specific pathogen had been detected and China’s organ 
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